1. Introduction {#s0005}
===============

Cryptococcus infection is relatively uncommon, except among immunocompromised individuals. The most common human pathogenic species is *Cryptococcus neoformans*. However, more and more opportunistic infections associated with non-neoformans cryptococcus have been reported. *Cryptococcus albidus* has recently been reported to be a rare cause of infection in humans. There are only 6 cases reported *C. albidus* as a cause of intracranial infection [@bib1]. Here we report another case of cryptococcus encephalitis caused by *C. albidus* who was the first case *C. albidus* encephalitis in an HIV patient. We also reviewed the literatures on risk factors, diagnosis and treatment of *C. albidus* extra-dermal infection in humans.

2. Case {#s0010}
=======

A 28-year-old heterosexual male attended emergency department and was preliminary diagnosed as encephalitis in April 6th 2013(day 0), then he was admitted to Intensive Care Unit of a teaching hospital. The patient complained diplopia, vomiting, tinnitus, vertigo and tumbling 3 times from day-3. He denied any family history and medical history except having a cold 2 weeks ago. The patient presented with neck stiffness, strabism and discontinuous confusion. He denied fever, headache and denied taking any medication. Physical examination revealed his left thorax signs of crusting herpes zoster.

When the patient was admitted, he was fully conscious and his urinary amount was about 100 ml/h. His blood pressure was 105/60 mmHg and pulse 115 /min, Body temperature 36.8 °C. At day 0, laboratory data revealed a white blood cell count of 6.69×10^9^ /l (84.0% neutrophils, 6.6% lymphocytes and 9.3% monocytes), hemoglobin level of 12.1 g/dl, platelet count 142×10^9^ /l and the count of CD4 positive white blood cell was 7.1 cells/μl and CD8 positive was 150.5 cells/μl, and normal urinalysis, liver function tests, chest radiograph and head computed tomography (CT).

The patient had signs of meningeal involvement and a lumbar puncture was performed 2 h after admitted. The pressure for the lumbar puncture was 32 cm H~2~O; cerebrospinal fluid (CSF) was clear with 8 white blood cells/μl and no red cell was found. CSF protein was 272 mg/dl (normal reference: 150--450 mg/dl) and glucose was 1.11 mmol/l (normal reference: 2.2--3.9 mmol/l). India ink staining revealed the presence of encapsulated yeast. Eight hours after admitted to hospital, the patient developed seizures and sank into a coma. Soon the patient appeared hypotension, abnormal breathing rhythm and was given tracheal intubation and mechanical ventilation. At day 1, he was reported HIV antibody positive.

After the patient admitted, he was administered with Ceftriaxone and Aciclovir. As India ink staining revealed the presence of encapsulated yeast, considering amphotericin B was unavailable in time, intravenous fluconazole therapy was immediately started. He died at day 3 duo to cureless low blood pressure.

At day 5 (2 days after patient\'s death), Culture of the CSF showed growth of *C. albidus*.

3. Discussion {#s0015}
=============

Cryptococcus infection is relatively uncommon, except among immunocompromised individuals. The most common human pathogenic species is *C. neoformans*. However, more and more opportunistic infections associated with non-neoformans cryptococcus have been reported. *C. albidus* has recently been reported to be a rare cause of infection in humans. There are only 20 reported cases of extra-dermal infection to date(see [Table 1](#t0005){ref-type="table"}) [@bib2; @bib3; @bib4; @bib5; @bib6; @bib7; @bib8; @bib9; @bib10; @bib11; @bib12; @bib13; @bib14; @bib15; @bib16]; most of cases were reported *C. albidus* as a cause of bacteremia in humans and only 6 cases as a cause of intracranial infection. Here we report another case of cryptococcus encephalitis caused by *C. albidus* who was the first case *C. albidus* encephalitis in an HIV patient. We also reviewed the literatures on risk factors, diagnosis and treatment of *C. albidus* infection in humans.

There are seven commonly recognized species of Cryptococcus. Neoformans cryptococcus is the most common human pathogenic species and non-neoformans cryptococcus have rarely reported as human pathogens. *C. albidus* is very similar to *C. neoformans* in morphology, but can be differentiated because it is phenol oxidase negative, and when grown on birdseed agar *C. neoformans* produces melanin causing the cells to take on a brown color while the *C. albidus* cells stay cream colored.

We report here a case of *C. albidus* encephalitis, based on available diagnostic methods, in a HIV-infected patient and review relevant literature on this infection. A comprehensive review of the literature was performed on case reports of infection due to *C. albidus* in patients in Medline from its inception until July 2013. Search terms employing the key words: fungus, infection, meningitis, encephalitis, Cryptococcus, non-neoformans, albidus. References in each manuscript were reviewed to identify additional cases of *C. albidus* infections.

*C. albidus* is a rare non-neoformans Cryptococcus that has been associated with human infections. Including our case, there have been a total of 21 cases of *C. albidus* extra-dermal infection in humans. Psychiatric history, chronic steroid exposure, organ transplantation, hematonosis, AIDS are associated risk factors. With the increase in use of medical technology and devices, greater number of immunocompromised patients accompanies appeared and change the risk factors of *C. albidus* infection. In the 11 cases reported in recent twenty years, all patients were concomitant with HIV/AIDS or organ transplantation patients except one with acute myeloid leukemia. So HIV/AIDS and transplantation become the main risk factors. Before our case, there were 6 *C. albidus* intracranial infection cases, but all of those cases were reported before 1978 and the risks were neurologic disease (3 cases), mental disease (2 cases), hematopathy (1 case) and exposure to pigeon excrement (1 case). Present case is the first *C. albidus* intracranial infection due to AIDS.

*C. albidus* infection has similar clinical manifestations as other cryptococcu infection. Cryptococcal encephalitis is one of the most important HIV-related opportunistic infections. Most patients with Cryptococcus encephalitis may absent the sign of fever, so did the patient in present case. Patients may show signs of meningeal irritation, cranial nerve palsies and focal neurologic abnormalities such as hemiparesis. CSF pressure may be normal or elevated, and the fluid is usually clear. Normal cell counts are common in immunosuppressed patients. CSF protein may be normal initially, subsequently rises, usually to levels not exceeding 200 mg/l. Glucose in normal or decreased but rarely below 10 mg/dl. Cryptococcal serum antigen assay is specific for the polysaccharide antigens found only on *C. neoformans*. So a negative serum Cryptococcus assay does not rule out infection by species of Cryptococcus other than neoformans. Fungal culture or India ink preparations are the best way to demonstrate *C. albidus* in both serum and CSF [@bib17]. In present case, the patient showed meningeal irritation sign and cranial nerve injuries. CSF pressure elevated and India ink staining reveal the presence of encapsulated yeast and CSF culture show *C. albidus* is the pathogen. Those all help the diagnosis of *C. albidus* encephalitis. Patient show no fever probably result from the immunosuppression caused by AIDS.

The treatment for *C. albidus* is not well defined. Amphotericin B has been modestly effective in the treatment of *C. albidus. C. albidus* encephalitis is considered had same therapy strategy as other cryptococcal encephalitis. A combination therapy of intravenous amphotericin B followed by fluconazole was recommended in treating cryptococcal encephalitis [@bib18]. While in a recent randomized, controlled trial about therapy for cryptococcal encephalitis in patients with HIV infection, result suggested that compared with amphotericin B alone, treatment by amphotericin B plus fluconazole showed no survival benefit. Amphotericin B plus flucytosine was associated with improved survival and this was the most recommend treatment strategy [@bib19].

In the 21 cases, 8 patients were died despite antifungal treatment were administered. Fifty seven percent (4 of 7 cases) *C. albidus* encephalitis patients were died. Cryptococcal encephalitis is a significant cause of morbidity and mortality among persons with HIV/AIDS and mortality remains high. It is reported that more than 50% patient were died in a survey sub-Saharan Africa [@bib20]. As the pathology of other cryptococcal encephalitis, main cause of death is brain stem compression. Even survival, patients often suffer optic atrophy, hydrocephalus, personality change and even dementia. This case emphasizes the importance of considering unusual emerging cryptococcal and suggests that *C. albidus* should be added to the increasing number of causative agents of fungal infections in immunocompromised patients such as HIV infection.
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###### 

summary of date from cases of *Cryptococcus albidus* extra-dermal infection in humans

  Year of case/published \[reference\]   Age   Sex   Risk factor(s)                                                                                                                                Infection site                  Duration of symptoms                                 Treatment                                                         Outcome
  -------------------------------------- ----- ----- --------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------- ---------------------------------------------------- ----------------------------------------------------------------- -------------------------------------------
  /1965                                  75    M     Psychiatric history, lung cancer on autopsy                                                                                                   Cerebrospinal fluid             1 Month                                              None                                                              Death
  /1968                                  73    F     Polycythemia vera                                                                                                                             Cerebrospinal fluid             5 Days                                               None                                                              Death
  /1970                                  48    M     None; glioblastoma of the basal ganglia later developed                                                                                       Cerebrospinal fluid             Unknown                                              None                                                              Survived
  1970/1972 [@bib2]                      68    M     Cigarette smoker, poor dentition                                                                                                              Lung                            6 Months                                             Amphotericin B (1.0 g)                                            Survived
  1971/1973 [@bib3]                      45    M     Air conditioner repairman, exposure to pigeon excrement                                                                                       Cerebrospinal fluid             3 Days                                               Amphotericin B (1.5 g)                                            Survived
  /1971                                  20    M     Psychiatric illness, neurologic illness                                                                                                       Cerebrospinal fluid             \>20 Months                                          None                                                              Survived
  1978/1980 [@bib4]                      29    M     Mentally retarded, juvenile rheumatoid arthritis, corticosteroids, alcoholic liver disease, arteriovenous malformation of cerebellar artery   Cerebrospinal fluid             36 Days after repair of arteriovenous malformation   Amphotericin B (unknown total dose)                               Death 18 days into therapy
  1987/1987 [@bib5]                      65    F     Acute myelogenous leukemia with severe neutropenia                                                                                            Blood                           5 Days                                               Amphotericin B (235 mg), Flucytosine (150 mg/kg/day for 7 days)   Death 11 days into therapy
  1987/1989 [@bib6]                      45    M     Pemphigus foliaceus, corticosteroids, cyclophosphamide                                                                                        Blood                           Unknown                                              Oral ketoconazole(unknown total dose)                             Survived
  1989/1993 [@bib7]                      37    M     End-stage renal disease, hemodialysis, coinfection with mucomycosis                                                                           Pleural fluid                   3 Weeks                                              Amphotericin B (1.9 g)                                            Survived
  /1993                                  40    M     AIDS, complicated by pneumocyctis carinii infection                                                                                           Blood                           2 Weeks                                              Oral fluconazole                                                  Survived but died later due to recurrence
  1996/1998 [@bib8]                      47    F     AIDS, complicated by CNS toxoplasmosis, MDS                                                                                                   Blood                           20 Days                                              Amphotericin B and flucytosine                                    Death 14 days into therapy
  1996/1996 [@bib9]                      38    M     AIDS, complicated by *Pneumocyctis carinii* infection                                                                                         Blood                           1 Month                                              Fluconazole and itraconazole                                      Death: cardiorespiratory arrest
  1998/1998 [@bib10]                     4     F     Acute lymphocytic leukemia                                                                                                                    Blood                           Unknown                                              Oral azithromycin and paromycin                                   Survived
  2004/2004 [@bib11]                     51    M     dependent diabetes; AML and chemotherapy; progenitor cell transplantation                                                                     Blood                           6 Weeks                                              Amphotericin B and oral Itraconazole                              Survived
  2001/2004 [@bib12]                     23    M     Renal transplantation                                                                                                                         Disseminate:blood, skin, lung   10 Days                                              Oral fluconazole                                                  Survived
  2001/2004 [@bib13]                     16    F     AIDS, inhale fluticasone due to asthma                                                                                                        Scleral ulceration              1 Week                                               Amphotericin B and itraconazole,                                  Resolved after 4 weeks therapy
  2004/2005 [@bib14]                     69    F     Corneal transplantation                                                                                                                       Keratitis                       7 Months                                             Remove the corneal button and repeat transplant                   Healed
  /2007 [@bib15]                         44    M     Immunosuppressive therapy because of Still\'s disease                                                                                         Lung                            6 Mouths                                             Amphotericin B                                                    Death after 10 days therapy
  2012/2013 [@bib16]                     55    M     Liver transplant                                                                                                                              Blood                           34 Days                                              Posaconazole, remove central venous catheter                      Survived
  Present case 2013                      31    M     AIDS                                                                                                                                          Cerebrospinal fluid             2 Weeks                                              Fluconazole                                                       Death within 2 days
